Literature DB >> 28768702

Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.

Anjelica Hodgson1,2, Bin Xu1,2, Raj Satkunasivam3, Michelle R Downes1,2.   

Abstract

AIMS: Inflammation and necrosis have been associated with prognosis in multiple epithelial malignancies. Our objective was to evaluate inflammation and necrosis in a cohort of patients with high-grade urothelial carcinomas of the bladder to determine their association with pathological parameters and their prognostic effect on relapse-free and disease-specific survival.
METHODS: A retrospective cohort that underwent radical cystectomy for urothelial carcinomas (n=235) was evaluated for invasive front and central inflammation using the Klintrup-Makinen assessment method. Necrosis was scored using a four-point scale. The relationship of inflammation and necrosis with stage, nodal status, carcinoma in situ, tumour size, margin status and vascular space invasion and the impact on relapse-free and disease-specific survival were calculated using appropriate statistical tests.
RESULTS: On multivariate analysis, invasive front inflammation (p=0.003) and necrosis (p=0.000) were independent predictors of relapse-free survival. Both invasive front inflammation (p=0.009) and necrosis (p=0.002) again were independent predictors of disease-specific survival. For pathological features, low invasive front inflammation was associated with lymphovascular space invasion (p=0.008), a positive soft tissue margin (p=0.028) and carcinoma in situ (p=0.042). Necrosis was statistically associated with tumours >3 cm in size (p=0.013) and carcinoma in situ (p<0.001).
CONCLUSIONS: Necrosis and invasive front inflammation are additional histological variables with independent prognostic relevance in high-grade urothelial carcinoma of the bladder. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  bladder; inflammation; necrosis; prognosis; urothelial

Mesh:

Year:  2017        PMID: 28768702     DOI: 10.1136/jclinpath-2017-204562

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Multi-omics analysis reveals the panoramic picture of necroptosis-related regulators in pan-cancer.

Authors:  Guanghao Li; Xiaoxuan Wang; Yongheng Liu; Huikai Li; Han Mu; Yanting Zhang; Qiang Li
Journal:  Aging (Albany NY)       Date:  2022-06-21       Impact factor: 5.955

2.  Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model.

Authors:  Jingyuan Li; Sihui Huang; Lijuan Zeng; Kan Li; Le Yang; Siyong Gao; Chenyu Guan; Sien Zhang; Xiaomei Lao; Guiqing Liao; Yujie Liang
Journal:  Cell Death Dis       Date:  2020-05-22       Impact factor: 8.469

3.  Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma.

Authors:  Ekaterina Olkhov-Mitsel; Anjelica Hodgson; Stan K Liu; Danny Vesprini; Jane Bayani; John M S Bartlett; Bin Xu; Michelle R Downes
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

4.  Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder.

Authors:  Anjelica Hodgson; Achim A Jungbluth; Nora Katabi; Bin Xu; Michelle R Downes
Journal:  Virchows Arch       Date:  2019-09-02       Impact factor: 4.064

5.  Development and Validation of a Necroptosis-Related Prognostic Model in Head and Neck Squamous Cell Carcinoma.

Authors:  Zhijing Zhang; Xinglin Hu; Dan Qiu; Yuchen Sun; Lei Lei
Journal:  J Oncol       Date:  2022-02-18       Impact factor: 4.375

6.  Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes.

Authors:  Chisato Ohe; Takashi Yoshida; Junichi Ikeda; Toyonori Tsuzuki; Riuko Ohashi; Haruyuki Ohsugi; Naho Atsumi; Ryosuke Yamaka; Ryoichi Saito; Yoshiki Yasukochi; Koichiro Higasa; Hidefumi Kinoshita; Koji Tsuta
Journal:  Biomedicines       Date:  2022-01-29

7.  Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma.

Authors:  Kosuke Miyai; Kazuki Kawamura; Keiichi Ito; Susumu Matsukuma; Hitoshi Tsuda
Journal:  BMC Cancer       Date:  2022-07-18       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.